Form 4 for PCRX Pacira BioSciences, Inc.
Accepted 2024-07-03 00:00:00 ET · period of report 2024-06-28 · accession 0001396814-24-000088 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-07-03 | 2024-07-01 | PCRX | SLONIN JONATHAN | Chief Medical Off | F - Tax | $28.46 | -914 | 98.4K | -0.9% | -$26.0K | |
| 2024-07-03 | 2024-07-02 | PCRX | SLONIN JONATHAN | Chief Medical Off | S - Sale | $28.25 | -2,836 | 95.6K | -3% | -$80.1K | |
| 2024-07-03 | 2024-06-28 | PCRX | SLONIN JONATHAN | Chief Medical Off | A - Grant | $24.32 | +437.27 | 99.3K | +0.4% | +$10.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-01 | F | D | 914 | $28.46 | 98,392.75 | D | — | — | |
| 2 | Common | Common Stock | 2024-07-02 | S | D | 2,836 | $28.25 | 95,556.75 | D | — | — | |
| 3 | Common | Common Stock | 2024-06-28 | A | A | 437.27 | $24.32 | 99,306.75 | D | — | — |